Barclays PLC - Director's Dealing 2021

National Storage Mechanism | Additional information

FORM 8.3 - UDG HEALTHCARE PLC

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION


	Name of person dealing (Note 1)	Barclays PLC.
	Company dealt in	UDG HEALTHCARE PLC
	Class of relevant security to which the	ORD
	dealings being disclosed relate (Note 2)
	Date of dealing	13 August 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)


Class of relevant security:		ORD
		Long		Short
		Number	(%)	Number	(%)
(1)	Relevant securities
		11,068,070	4.39%	148,944	0.06%

(2)	Derivatives (other than options):
		6,767	0.00%	3,032,524	1.20%

(3)	Options and agreements to
	purchase/sell:	0	0.00%	0	0.00%

(4)	TOTAL:
		11,074,837	4.40%	3,181,468	1.26%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)


Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales


Purchase/sale	Number of relevant securities	Price per unit
Purchase	419	10.7894 GBP
Purchase	7,663	10.8000 GBP
Purchase	45,405	10.7900 GBP
Purchase	99,891	10.7889 GBP
Sale	1,844	10.7923 GBP
Sale	2,223	10.7900 GBP
Sale	7,233	10.8005 GBP
Sale	1,508,838	10.7846 GBP

(b) Derivatives transactions (other than options transactions)


Product Name	Nature of transaction	Number of relevant securities	Price per
			unit
CFD	Long	1	10.7900 GBP
SWAP	Long	1,414	10.7900 GBP
SWAP	Short	60	10.7800 GBP
CFD	Short	145,236	10.7902 GBP

(i) Writing, selling, purchasing or varying


Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)

(ii) Exercising


Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)


Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None


Is a Supplemental Form 8 (Open Positions) attached?	NO
Date of disclosure:	16 Aug 2021
Contact name:	Large Holdings Regulatory Operations
Telephone number:	020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection